Tenzingplasty improved NIHSS by 4.4 points from 12.2 to 7.8 and improved 30-day mRS distribution with no symptomatic intracranial hemorrhage or dissections in 18 adults with symptomatic ICAD without LVO.
Does Tenzingplasty improve neurologic outcomes and vessel patency safely in adult patients with symptomatic intracranial atherosclerotic disease without large vessel occlusion?
Tenzingplasty appears to be a safe and feasible alternative to traditional balloon angioplasty for symptomatic, non-occlusive intracranial atherosclerotic disease, demonstrating clinical improvement without 30-day procedural complications in a small cohort.
Absolute Event Rate: 7.8% vs 12.2%
T-Plasty for the elective treatment of chronic symptomatic ICAD and acute hypoperfusion syndrome is an option for improving neurologic outcome.
Behzadi et al. (Thu,) conducted a other in Adult patients (≥18 years) with symptomatic non-occlusive intracranial atherosclerotic disease (ICAD) without large vessel occlusion (LVO) after maximal medical therapy failure (n=18). Tenzingplasty (T-Plasty) using Tenzing delivery catheter was evaluated on Change in National Institute of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) at 30 days, procedural and post-procedural complications. Tenzingplasty improved NIHSS by 4.4 points from 12.2 to 7.8 and improved 30-day mRS distribution with no symptomatic intracranial hemorrhage or dissections in 18 adults with symptomatic ICAD without LVO.